FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1162483003: Infigratinib (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4589750015 Infigratinib en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4589751016 Infigratinib (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Infigratinib Is a Phenylurea compound (substance) true Inferred relationship Some
Infigratinib Is a Aminopyrimidine (substance) true Inferred relationship Some
Infigratinib Is a Fibroblast growth factor receptor inhibitor true Inferred relationship Some
Infigratinib This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Fibroblast growth factor receptor inhibitor (disposition) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Infigratinib-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Infigratinib Inferred relationship Some 1
Product containing only infigratinib (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Infigratinib Inferred relationship Some 1
Infigratinib-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Infigratinib Inferred relationship Some 1
Infigratinib only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Infigratinib Inferred relationship Some 1
Product containing precisely infigratinib 25 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Infigratinib Inferred relationship Some 1
Product containing precisely infigratinib 25 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Infigratinib Inferred relationship Some 1
Infigratinib 100 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Infigratinib Inferred relationship Some 1
Infigratinib 100 mg oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Infigratinib Inferred relationship Some 1

This concept is not in any reference sets

Back to Start